Tormod K Guren Selected Research

Tormod K Guren Research Topics

9	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2014
5	Neoplasms (Cancer) 01/2023 - 12/2009
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2019
2	Neoplasm Metastasis (Metastasis) 11/2019 - 05/2015
1	Neurofibroma 11/2023
1	Thyroid Neoplasms (Thyroid Cancer) 01/2023
1	Follicular Adenocarcinoma 01/2023
1	Colitis 11/2019
1	Autoimmune Diseases (Autoimmune Disease) 11/2019
1	Rectal Neoplasms (Rectal Cancer) 01/2017
1	Asthenia 12/2015
1	Leukemia 12/2009
1	Hepatocellular Carcinoma (Hepatoma) 02/2008
1	Breast Neoplasms (Breast Cancer) 11/2005

5	Cetuximab (Erbitux)FDA Link 10/2019 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2015
3	IpilimumabIBA 01/2022 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2019
2	NivolumabIBA 11/2019 - 01/2019
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017 - 12/2015
2	dalotuzumabIBA 01/2017 - 12/2015
2	Epidermal Growth Factor (EGF)IBA 09/2016 - 02/2008
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2015 - 01/2014
2	Tyrosine Kinase InhibitorsIBA 02/2008 - 11/2005
1	pembrolizumabIBA 01/2023
1	binimetinibIBA 10/2019
1	encorafenibIBA 10/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	ErbB Receptors (EGF Receptor)IBA 09/2016
1	AntibodiesIBA 09/2016
1	Proteins (Proteins, Gene)FDA Link 09/2016
1	Tissue Inhibitor of Metalloproteinase-1IBA 09/2016
1	Monoclonal AntibodiesIBA 12/2015
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2015
1	Messenger RNA (mRNA)IBA 12/2015
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2015
1	Urokinase Plasminogen Activator ReceptorsIBA 11/2015
1	Dinoprostone (PGE2)FDA Link 02/2008
1	RTKI cpdIBA 02/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2008
1	Gefitinib (Iressa)FDA Link 02/2008
1	Trastuzumab (Herceptin)FDA Link 11/2005
1	Imatinib Mesylate (Gleevec)FDA Link 11/2005